We discovered mcl-1, a member of the bcl-2 family, by screening for genes that increase in expression early in the differentiation of ML-1 human myeloblastic leukemia cells. Our further studies have revealed mcl-1 to be similar to bcl-2 in some characteristics and different in others: For example, mcl-1 can enhance cell viability under some apoptosis-inducing conditions, although it may have effects less pronounced than those of bcl-2. Similarly, mcl-1 is prominent in mitochondria and exhibits a distribution that overlaps with, but is not identical to, that of bcl-2. Finally, mcl-1 co-immunoprecipitates with a 22 KD protein, as does bcl-2. The mcl-1 protein exists as three species, visualized as three closely spaced bands on blots. A shift in the relative abundance of these bands occurs during ML-1 cell differentiation. In addition, certain of these bands are phosphorylated, phosphorylation occurring on serine. We now plan to determine how the expression and phosphorylation of the different species of mcl-1 relates to function.
In Aim I, we will complete the characterization of the effects of mcl-1 on cell viability, determining whether mcl-1 can inhibit cell death under a broad range of conditions as can bcl-2.
In Aim II, we will identify the 22 KD protein and further characterize its interaction with mcl-1.
In Aim III, we will identify the structural differences that distinguish the different species of the mcl-1 protein; we will determine, for example, how phosphorylation contributes to the appearance of these different species.
In Aim I V, we will determine how phosphorylation (and any other modifications of mcl-1 discovered in Aim III) influence both the effect of mcl-1 on cell viability and the interaction of mcl-1 with the 22 KD protein.
In Aim V, we will determine when (e.g., how early) in the death process mcl-1 must be expressed in order to exert its effects on viability. Taken together, these studies on mcl-1 will contribute to an emerging understanding of how genes in the bcl-2 family are regulated, and how these genes, in turn, regulate cell viability versus death.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA057359-06
Application #
2390754
Study Section
Pathology B Study Section (PTHB)
Project Start
1992-06-01
Project End
2000-03-31
Budget Start
1997-04-01
Budget End
1998-03-31
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Pharmacology
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Gui, Jingang; Hu, Zhuting; Tsai, Ching-Yi et al. (2015) MCL1 enhances the survival of CD8+ memory T Cells after viral infection. J Virol 89:2405-14
Nifoussi, Shanna K; Ratcliffe, Nora R; Ornstein, Deborah L et al. (2014) Inhibition of protein phosphatase 2A (PP2A) prevents Mcl-1 protein dephosphorylation at the Thr-163/Ser-159 phosphodegron, dramatically reducing expression in Mcl-1-amplified lymphoma cells. J Biol Chem 289:21950-9
Huang, Li-Hao; Gui, Jingang; Artinger, Erika et al. (2013) Acat1 gene ablation in mice increases hematopoietic progenitor cell proliferation in bone marrow and causes leukocytosis. Arterioscler Thromb Vasc Biol 33:2081-7
Nifoussi, Shanna K; Vrana, Julie A; Domina, Aaron M et al. (2012) Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer. PLoS One 7:e47060
Gui, Jingang; Morales, Amanda J; Maxey, Sophie E et al. (2011) MCL1 increases primitive thymocyte viability in female mice and promotes thymic expansion into adulthood. Int Immunol 23:647-59
De Biasio, Alfredo; Vrana, Julie A; Zhou, Ping et al. (2007) N-terminal truncation of antiapoptotic MCL1, but not G2/M-induced phosphorylation, is associated with stabilization and abundant expression in tumor cells. J Biol Chem 282:23919-36
Kobayashi, Shogo; Lee, Sun-Hee; Meng, Xue W et al. (2007) Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1. J Biol Chem 282:18407-17
Marriott, Helen M; Bingle, Colin D; Read, Robert C et al. (2005) Dynamic changes in Mcl-1 expression regulate macrophage viability or commitment to apoptosis during bacterial clearance. J Clin Invest 115:359-68
Domina, Aaron M; Vrana, Julie A; Gregory, Mark A et al. (2004) MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol. Oncogene 23:5301-15
Michels, Jorg; O'Neill, Jason W; Dallman, Claire L et al. (2004) Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 23:4818-27

Showing the most recent 10 out of 22 publications